secwatch / observer
8-K filed June 27, 2023, 7:59 PM ET ticker DFTX CIK 0001813814
other material confidence high sentiment neutral materiality 0.15

MindMed annual meeting elects six board nominees; FCM MM Holdings challenges preliminary vote results

Definium Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Definium Therapeutics, Inc. shareholders approved Appointment of KPMG LLP as auditor of the Company until the close of the 2024 Annual Meeting at the 2023-06-21 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-21
Exact text from the filing
The shareholders approved the appointment of KPMG LLP as the auditor of the Company until the close of the 2024 Annual Meeting, by the following votes: Votes For Votes Against Votes Abstain 14,857,596 394,019 1,078,880
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Definium Therapeutics, Inc. shareholders approved Election of Directors: Company Board Nominees and FCM MM Holdings, LLC Nominees at the 2023-06-21 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-21
Exact text from the filing
The Company's six nominees, Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs, and Carol A. Vallone, were each elected to serve as a member of the Company's Board of Directors (the "Board") until the 2024 annual general meeting of shareholders (the "2024 Annual Meeting") and until his or her successor is duly elected or qualified, by the following votes: Company Board Nominee Votes For Votes Withheld Robert Barrow 8,154,619 6,260,614 Dr. Suzanne Bruhn 10,708,185 3,707,052 Dr. Roger Crystal 8,208,815 6,206,151 David Gryska 12,248,893 2,166,343 Andreas Krebs 8,099,276 6,315,960 Carol A. Vallone 8,125,466 6,289,772 FCM MM Holdings, LLC Nominee Votes For Votes Withheld Dr. Scott Freeman 6,023,932 7,779,083 Dr. Farzin Farzaneh 6,022,144 7,780,172 Vivek Jain 5,950,387 7,852,629 Alexander J. Wodka 5,921,398 7,881,619
View on SEC.gov

1180 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Definium Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-030195
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.